New HIV combo could free patients from daily pills

NCT ID NCT07054931

Recruiting now Disease control Sponsor: University of Oxford Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025

Summary

This study tests whether combining an HIV vaccine with powerful antibodies can help people with HIV control the virus without daily antiretroviral therapy. 48 adults with well-controlled HIV will receive the combination and briefly stop their regular medication to see if their immune system can keep the virus in check. The goal is to find a way to achieve long-term virus control, not a cure, as participants may still need monitoring or future treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Centre for Clinical Vaccinology and Tropical Medicine (CCVTM)
RECRUITING

Oxford, OX3 7LJ, United Kingdom

Contact Phone: •••-•••-•••• Email: •••••@•••••
Guys and St Thomas' NHS Trust
RECRUITING

London, SE1 7EH, United Kingdom

Contact Phone: •••-•••-•••• Email: •••••@•••••
St Mary's Clinical Trial Unit
RECRUITING

London, W2 1NY, United Kingdom

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV